HC Deb 14 November 1996 vol 285 cc346-8W
Mr. Flynn

To ask the Secretary of State for Northern Ireland how many elderly(a) men and (b) women have been admitted to hospital in Northern Ireland as a consequence of an adverse reaction to (i) non-steroidal anti-inflammatory drugs, (ii) phenothiazines, (iii) diuretics, (iv) analgesics, (v) night sedation, (vi) digoxin, (viii) laxatives, (viii) corticosteroids, (ix) beta blockers and (x) aminophylline in each of the last five years; and if he will make a statement. [2906]

Mr. Moss

The table gives the number of patients aged 65 years or over who were recorded as admitted to hospital in Northern Ireland in each of the last five years with a recorded adverse reaction in terms of the categories requested.

When interpreting these figures, it should be noted that they are likely to understate the incidence of adverse reaction because this is not always recorded, particularly in earlier years, in the level of detail required by the question.

1991–92 1992–93 1993–94 1994–95 1995–96
M F M F M F M F M F
Analgesics 2 5 3 3 2 8 8 14 9 18 Analgesics
Night Sedation2 0 0 0 0 0 0 0 0 2 2 Night Sedation
Digoxin 1 8 5 14 7 7 9 20 7 25 Diogoxin
Laxatives3 0 0 0 0 1 1 0 0 0 1 Laxatives
Corticosteriods 0 1 0 3 2 2 2 7 4 7 Corticosteriods
Beta Blockers 3 2 3 3 3 12 9 14 22 27 Beta Blockers
Aminophyline 0 0 0 0 1 0 1 0 0 0 Aminophyline

Source: Hospital Inpatients System (Figures for 1995–96 provisional)

Owing to non-specific information requested, 1,2,3 have had to be interpreted as follows:

1NSAIDs: Figures given refer to recorded adverse reaction to anti-inflamatory drugs (ICD9 E946.0).

2Night Sedation: Figures given refer to recorded adverse reaction to sleeping pillos (ICD9 E937.9).

3Laxatives: Figures given refer to recorded adverse reaction to mineral oil laxative (ICD9 E943.2).

Mr. Flynn

To ask the Secretary of State for Northern Ireland what percentage of, and how many, people admitted to hospital in Northern Ireland have been suffering from adverse reactions to a prescribed drug in each of the last five years and in age bands of 10 years; and if he will make a statement. [2908]

Mr. Moss

The information requested is set out in the tables.

When interpreting these figures, it should be noted that they are likely to understate the incidence of adverse reaction because this is not always recorded, particularly in earlier years, in the level of detail required by the question.

Age group Total discharges and deaths D and Ds from adverse reaction to drugs Percentage
1991–92
0 to 9 41,113 13 0.03
10 to 19 23,233 9 0.04
20 to 29 47,852 12 0.03
30 to 39 38,509 16 0.04
40 to 49 31,359 22 0.07
50 to 59 31,531 24 0.08
60 to 69 39,127 41 0.10
70 to 79 37,164 41 0.11
80 to 89 19,459 19 0.10
90+ 2,689 4 0.15
Total 312,036 201 0.06
1992–93
0 to 9 45,218 21 0.05
10 to 19 23,067 9 0.04
20 to 29 48,532 22 0.05
30 to 39 40,188 16 0.04
40 to 49 31,342 36 0.11
50 to 59 33,626 41 0.12
60 to 69 41,710 55 0.13
70 to 79 38,954 78 0.20
80 to 89 20,126 42 0.21
90+ 2,775 6 0.22
Total 325,538 326 0.10
1993–94
0 to 9 48,444 123 0.05
10 to 19 23,536 16 0.07
20 to 29 46,154 39 0.08
30 to 39 42,987 34 0.08
40 to 49 33,208 42 0.13
50 to 59 36,844 61 0.13
60 to 69 45,215 78 0.17
70 to 79 43,943 93 0.21
Age group Total discharges and deaths D and Ds from adverse reaction to drugs Percentage
80 to 89 22,480 53 0.24
90+ 3,082 9 0.29
Total 345,893 448 0.13
1994–95
0 to 9 55,841 18 0.03
10 to 19 25,696 20 0.08
20 to 29 52,870 39 0.07
30 to 39 51,756 47 0.09
40 to 49 37,831 47 0.12
50 to 59 41,445 58 0.14
60 to 69 49,006 98 0.20
70 to 79 48,664 135 0.28
80 to 89 24,985 80 0.32
90+ 3,398 14 0.41
Total 391,492 556 0.14
1995–96
0 to 09 62,837 21 0.03
10 to 19 26,388 40 0.15
20 to 29 51,738 57 0.11
30 to 39 54,393 72 0.13
40 to 59 39,791 64 0.16
50 to 59 42,724 118 0.28
60 to 69 50,719 150 0.30
70 to 79 51,460 166 0.32
80 to 89 26,496 120 0.45
90+ 3,797 20 0.53
Total 410,343 828 0.20

Forward to